Exhibiting at HOTELEX Shanghai 2025

Nutricia Trading (Shanghai) Co., Ltd. operates as the Chinese subsidiary of Nutricia, a part of Danone’s Specialized Nutrition division. Located in Shanghai, the company plays a pivotal role in the distribution, marketing, and customer support of advanced medical and infant nutrition products across China. With a focus on science-driven healthcare solutions, Nutricia Shanghai brings clinically proven nutrition products to patients, healthcare providers, and families.

Core Business and Offerings

Nutricia Shanghai's product portfolio spans three major segments:

• Medical Nutrition

  • Amino Acid-Based Formulas for individuals with multiple food allergies or metabolic disorders.
  • Specialized Rice-Based Nutritional Powders designed for children with protein intolerance or gastrointestinal complications.

• Infant Nutrition

  • Specialized Infant Formula, including hypoallergenic formulas and preterm infant solutions under brands like Neocate and Nutrilon.

• Healthcare Accessories

  • Childcare products including strollers, thermos cups, and wet wipes, designed to complement nutrition and promote overall wellness.

These offerings are primarily aimed at pediatricians, hospitals, pharmacies, and direct consumers managing dietary restrictions or clinical conditions.

Specialization and Unique Strengths

Nutricia Trading (Shanghai) stands out for its integration of clinical nutrition with medical research, delivering products that are not only food-grade but are recognized as therapeutic tools in the management of various conditions. Distinctive strengths include:

• Strong backing by Danone Research, enabling continued innovation in medical foods and patient-specific nutrition.
• Active collaboration with Chinese hospitals and medical institutions for clinical trials and patient outcome studies.
• A robust supply chain that ensures availability of niche products that meet China’s National Medical Insurance and Food Safety standards.

The company serves as a bridge between global nutritional science and the localized dietary needs of Chinese consumers.

Financial Performance and Trade Data

As part of the broader Danone Group, Nutricia’s financial strength is well-documented. In FY 2023, Danone’s Specialized Nutrition segment (which includes Nutricia) reported €7.5 billion in global revenue, with China listed as a key strategic market.

In terms of trade and import:

• Nutricia Shanghai has been listed in China’s Customs import data as a top importer of medical infant formula and specialized amino acid-based nutrition.
• The company has over 80 documented imports in the last two years, primarily through the Port of Shanghai, with product origins from Europe (notably the Netherlands and France).
• Average monthly import volume is 5–10 metric tons, with strong consistency in SKU rotation and product compliance.

Target Market

Nutricia Shanghai targets:

• Hospitals and pediatric clinics prescribing dietary solutions for infants and children with metabolic issues.
• Pharmacies and DTC e-commerce platforms catering to caregivers of allergic or intolerant children.
• Medical practitioners and nutritionists involved in dietetic therapy.

Its reach includes Tier 1 and Tier 2 cities, with growing penetration into provincial hospitals and specialty care centers.

Capabilities and Infrastructure

The company operates from a strategically located headquarters in Shanghai, equipped with:

• A regulatory and compliance team to ensure full alignment with Chinese FDA and health authority policies.
• A logistics hub for rapid distribution across mainland China.
• Dedicated customer care and medical affairs units, offering nutritional guidance and product information.

Nutricia also runs consumer education initiatives through online webinars, pediatric forums, and partnership with parent support organizations.

Certifications and Compliance

Nutricia products distributed in China conform to:

• China’s Food Safety Law for Infant Formula
• European Food Safety Authority (EFSA) regulations
• ISO 13485 and ISO 22000 certifications for product safety and quality control

Specialized formulas are also compliant with GB 10765 and GB 29921 standards in China, ensuring clinical suitability and safety.

Recognition and Testimonials

Nutricia Shanghai has earned acclaim from:

• Pediatric associations in China for supporting rare disease dietary care.
• Hospital procurement bodies for consistent product supply and regulatory adherence.
• Thousands of caregiver testimonials shared on Mom-and-Baby forums, praising Neocate for helping children with milk protein allergies.

The company has also been featured in healthcare innovation roundtables and published collaborative case studies in medical journals.

Major Achievements

• Successfully introduced Neocate and Nutrilon brands into over 500 hospitals across China.
• Leading participant in China’s Rare Disease Nutrition Programs, especially in managing phenylketonuria and other inborn errors of metabolism.
• Recognized by Shanghai Municipal Health Commission for contributions to medical nutrition accessibility.
• Expanded to include digital healthcare integration with nutritionist-supported online consultations.

Nutricia Trading (Shanghai) Co., Ltd. continues to elevate standards in clinical nutrition, providing tailored nutritional therapies that improve health outcomes for children and medically vulnerable populations in China.